BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37080606)

  • 21. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients borderline for surgery due to impaired pulmonary function.
    Tomita N; Okuda K; Kita N; Niwa M; Hashimoto S; Murai T; Ishikura S; Nakanishi R; Shibamoto Y
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):634-641. PubMed ID: 35098662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
    Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
    Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
    Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective comparison between definitive stereotactic body radiotherapy and radical surgery for 538 patients with early-stage non-small cell lung cancer in a single institution.
    Miki Y; Yamashita H; Nakajima J; Karasaki T; Kitano K; Katano A; Takenaka R; Ogita M; Sawayanagi S; Minamitani M; Jinnouchi H; Noyama T; Takeuchi K; Ishida A; Abe O
    J Cancer Res Ther; 2023; 19(5):1350-1355. PubMed ID: 37787307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy of stereotactic body radiotherapy and thoracoscopic surgery in the treatment of early-stage non-small cell lung cancer.
    Li X; Niu C; Chen Q; Chen X
    J BUON; 2020; 25(3):1497-1503. PubMed ID: 32862596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.
    Ezer N; Veluswamy RR; Mhango G; Rosenzweig KE; Powell CA; Wisnivesky JP
    J Thorac Oncol; 2015 Aug; 10(8):1201-6. PubMed ID: 26200275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
    Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
    Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin.
    Müller JA; Vordermark D; Medenwald D
    Strahlenther Onkol; 2023 Jul; 199(7):658-667. PubMed ID: 36912978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.
    Boyer MJ; Williams CD; Harpole DH; Onaitis MW; Kelley MJ; Salama JK
    J Thorac Oncol; 2017 Dec; 12(12):1814-1823. PubMed ID: 28951090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.
    Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman B; Senan S
    Radiother Oncol; 2011 Nov; 101(2):240-4. PubMed ID: 21775007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies.
    Viani GA; Gouveia AG; Yan M; Matsuura FK; Moraes FY
    J Bras Pneumol; 2022; 48(3):e20210390. PubMed ID: 35508065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
    Mayne NR; Lin BK; Darling AJ; Raman V; Patel DC; Liou DZ; D'Amico TA; Yang CJ
    Ann Surg; 2020 Dec; 272(6):925-929. PubMed ID: 33074904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
    Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
    Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.
    Dworzecki T; Idasiak A; Syguła D; Dworzecka U; Suwiński R
    Neoplasma; 2012; 59(1):114-20. PubMed ID: 22103905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.